Core Laboratories (CLB) Deferred Taxes (2022 - 2026)

Core Laboratories has reported Deferred Taxes for 5 years, with the latest figure at $3.7 million in Q1 2026.

• For the quarter ending Q1 2026, Deferred Taxes rose 104.68% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $482000.0 (down 87.86% YoY), and the FY2025 full-year result was -$1.4 million, down 110.68% from the prior year.
• Deferred Taxes for Q1 2026 stood at $3.7 million, up from -$6.0 million in the prior quarter.
• The five-year high for Deferred Taxes was $11.9 million in Q2 2023, with the low at -$6.0 million in Q4 2025.
• Historically, Deferred Taxes has averaged $835533.3 across 5 years, with a median of $1.3 million in 2025.
• The largest YoY upside for Deferred Taxes was 259.95% in 2025 against a maximum downside of 947.73% in 2025.
• Core Laboratories' Deferred Taxes stood at -$2.2 million in 2022, then tumbled by 76.16% to -$3.9 million in 2023, then soared by 85.5% to -$572000.0 in 2024, then tumbled by 947.73% to -$6.0 million in 2025, then soared by 162.06% to $3.7 million in 2026.
• The last three Deferred Taxes figures came in at $3.7 million (Q1 2026), -$6.0 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.